Identification of Epigallocatechin-3-gallate in Green Tea Polyphenols As a Potent Inducer of P53-dependent Apoptosis in the Human Lung Cancer Cell Line A549
Overview
Affiliations
The effects of green tea polyphenols on cultured cancer cells have been well characterized, especially the effects of epigallocatechin-3-gallate (EGCg), since EGCg suppresses oncogenic signaling pathways and induces cell cycle arrest or apoptosis by regulating cell cycle-associated proteins. In the present study, we attempted to identify signaling pathways or target molecules regulated by each of or a mixture of green tea polyphenols, including epicatechin (EC), epicatechin-3-gallate (ECg), epigallocatechin (EGC), and EGCg, in the human lung cancer cell line A549. ECg, EGC, and a catechin mixture, in addition to EGCg, significantly decreased cell viability. In contrast, caspase 3/7 activity, an apoptosis indicator, was specifically induced by EGCg. By conducting a series of luciferase-based reporter assays, we revealed that the catechin mixture only up-regulates the p53 reporter. EGCg was a more potent inducer of p53-dependent transcription, and this induction was further supported by the induced level of p53 protein. RNA interference (RNAi)-mediated p53 knockdown completely abolished EGCg-induced apoptosis. Finally, a proteome and western blot analysis using approximately 70 different antibodies failed to detect up-regulated proteins in catechin mixture-treated A549 cells. Taken together, these results indicate that EGCg, among several green tea polyphenols, is a potent apoptosis inducer that functions exclusively through a p53-dependent pathway in A549 cells.
da Conceicao P, Ayusso G, Carvalho T, Duarte Lima M, Marinho M, Moraes F Viruses. 2025; 17(2).
PMID: 40007013 PMC: 11860591. DOI: 10.3390/v17020258.
Muruthi C, Ngugi M, Runo S, Mwitari P J Evid Based Integr Med. 2023; 28:2515690X231187711.
PMID: 37489007 PMC: 10387709. DOI: 10.1177/2515690X231187711.
Zhang L, Wen J, Hai L, Wang Y, Yan L, Gao W J Thorac Dis. 2023; 14(12):5029-5038.
PMID: 36647481 PMC: 9840036. DOI: 10.21037/jtd-22-1791.
Al Safi M, Rashid H, Afifi F, Talib W Front Nutr. 2022; 9:900506.
PMID: 35845806 PMC: 9283951. DOI: 10.3389/fnut.2022.900506.
Uprety B, Chandran R, Arderne C, Abrahamse H Pharmaceutics. 2022; 14(1).
PMID: 35057107 PMC: 8780642. DOI: 10.3390/pharmaceutics14010211.